DESTINY-Breast02 Confirms Benefit of Trastuzumab Deruxtecan in Previously Treated Patients With HER2+ Metastatic Breast CancerDecember 10th 2022
In the second-line setting, patients with advanced HER2-positive breast cancer derived a superior clinical benefit with trastuzumab deruxtecan compared with treatment with physician’s choice of treatment.
Fewer Cycles of Oxaliplatin Treatment May Reduce Incidence of Severe Neuropathy for Patients With Stage III Colon CancerNovember 29th 2022
An observational study of 2450 patients with stage III colon cancer identified key factors that may increase a patient’s risk of oxaliplatin-induced peripheral neuropathy.
Adding Cediranib to Olaparib Increases Treatment Efficacy, But Raises Toxicity Concerns, in mCRPCOctober 29th 2022
A regimen of cediranib and olaparib improved radiographic progression-free survival in patients with metastatic castration-resistant prostate cancer compared with olaparib monotherapy. However, the rate of dose reductions was doubled with the combination.
Aliènne Salleroli on Establishing Equity, Diversity, and Inclusion Throughout Oncology PracticeApril 29th 2022
The framework for establishing equity, diversity, and inclusion throughout oncology nursing already exists within the standard for health and safety, explains Aliènne Salleroli, MS, BSN, RN, OCN.
Bypassing the SICU May Improve Patient OutcomesOctober 19th 2018
Smilow Cancer Hospital tested sending patients directly from the post–anesthesia care unit (PACU) to the surgical oncology unit after head and neck surgery to reduce length of stay, postoperative complications, and readmission rates of patients.
Message Delivered? Assessing the Effectiveness of Patient Education InteractionsMay 24th 2017
Effective communication can impact patient outcomes, and the patient perspective is critical in assessing these professional communicational skills.
Starting at "Zero" - Achieving Hospice and Palliative Care CertificationSeptember 22nd 2016
Leaders from Yale Smilow saw an opportunity to create an educational program to facilitate certification of inpatient and outpatient nurses in hospice and palliative care.
Two, High-Dose Flu Shots Help High-Risk Patients Avoid InfectionDecember 7th 2015
Although patients with multiple myeloma and other plasma cell disorders (PCDs) are routinely vaccinated against influenza, studies show that a one-time flu shot does not confer an adequate immune response in these high-risk patients.
Mark Lazenby on Universality of Psychosocial Concerns Following Cancer DiagnosisSeptember 22nd 2015
Mark Lazenby, PhD, associate professor at Yale School of Nursing and incoming president of American Psychosocial Oncology Society (APOS), discusses the universality of psychosocial concerns following a cancer diagnosis.